OrganiGram Holdings Inc (OGI)
1.51
+0.01
(+0.67%)
USD |
NASDAQ |
Nov 29, 16:00
1.55
+0.04
(+2.65%)
After-Hours: 07:38
OrganiGram Holdings Net Income (Quarterly): 2.059M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.059M |
| March 31, 2024 | -20.07M |
| December 31, 2023 | -11.57M |
| May 31, 2023 | -157.12M |
| February 28, 2023 | -5.549M |
| November 30, 2022 | 3.951M |
| August 31, 2022 | -4.761M |
| May 31, 2022 | -2.190M |
| February 28, 2022 | -3.182M |
| November 30, 2021 | -1.039M |
| August 31, 2021 | -20.86M |
| May 31, 2021 | -3.232M |
| February 28, 2021 | -52.04M |
| November 30, 2020 | -26.07M |
| August 31, 2020 | -28.70M |
| May 31, 2020 | -64.22M |
| February 29, 2020 | -5.187M |
| November 30, 2019 | -0.6526M |
| August 31, 2019 | -16.98M |
| May 31, 2019 | -7.594M |
| February 28, 2019 | -4.792M |
| November 30, 2018 | 22.53M |
| August 31, 2018 | 13.75M |
| May 31, 2018 | 2.196M |
| February 28, 2018 | 0.8545M |
| Date | Value |
|---|---|
| November 30, 2017 | -1.115M |
| August 31, 2017 | -1.580M |
| May 31, 2017 | -1.741M |
| February 28, 2017 | -4.350M |
| November 30, 2016 | -0.5699M |
| August 31, 2016 | 0.4817M |
| May 31, 2016 | 0.2829M |
| February 29, 2016 | 0.0397M |
| November 30, 2015 | -0.1524M |
| August 31, 2015 | 0.0445M |
| May 31, 2015 | 0.0967M |
| February 28, 2015 | -0.5287M |
| November 30, 2014 | -0.7322M |
| July 31, 2014 | -0.1728M |
| April 30, 2014 | -0.0219M |
| January 31, 2014 | -0.0147M |
| October 31, 2013 | -0.18M |
| July 31, 2013 | -0.0123M |
| April 30, 2013 | -0.0029M |
| January 31, 2013 | -0.0591M |
| October 31, 2012 | -0.2563M |
| July 31, 2012 | -0.0597M |
| April 30, 2012 | -0.0437M |
| January 31, 2012 | -0.0793M |
| October 31, 2011 | -0.0064M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-157.12M
Minimum
May 2023
3.951M
Maximum
Nov 2022
-23.52M
Average
-5.549M
Median
Feb 2023
Net Income (Quarterly) Benchmarks
| Tilray Brands Inc | -39.16M |
| Aurinia Pharmaceuticals Inc | 14.35M |
| Edesa Biotech Inc | -1.668M |
| Lexaria Bioscience Corp | -2.185M |
| Xenon Pharmaceuticals Inc | -62.79M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 30.00M |
| Total Expenses (Quarterly) | 33.69M |
| EPS Diluted (Quarterly) | 0.019 |
| Enterprise Value | 97.97M |
| Gross Profit Margin (Quarterly) | 34.12% |
| Profit Margin (Quarterly) | 6.86% |
| Earnings Yield | -55.76% |
| Normalized Earnings Yield | 58.82 |